Follow us on Twitter
twitter icon@FreshPatents


Dimethyl patents

      

This page is updated frequently with new Dimethyl-related patent applications.




 Enhancement solution for enhancing chemiluminescence and  preparing chemiluminescent solution patent thumbnailnew patent Enhancement solution for enhancing chemiluminescence and preparing chemiluminescent solution
Disclosed are an enhancement solution for enhancing chemiluminescence, and a method for preparing a chemiluminescent solution. The method comprises step a: dissolving methylglucamine in water, adjusting the ph to 8-9, then adding an n-alkyldimethylmannosamine quaternary ammonium salt, acridine orange, bsa, glycine, mgcl2, and zncl2 respectively to a diethanolamine solution, stirring to dissolve them, and diluting to a constant volume, to obtain an enhancement solution; and step b: diluting a chemiluminescent substrate with the enhancement solution, to obtain a chemiluminescent solution.
Shenzhen Maxchemtech Co., Ltd.


 Method for preparing polycarbosilane by catalytic rearranging patent thumbnailnew patent Method for preparing polycarbosilane by catalytic rearranging
This invention provides a method for preparing a polycarbosilane by decomposition and rearrangement a cyclic silane compound or chain polysilane under the catalysis of a boron-containing catalyst in a trace amount (less than 1 wt %). In the method, poly(dimethylsilane) (denoted as pdms) or a thermal decomposition product thereof, i.e., a liquid silane-carbosilane compound (denoted as lps), is used as the raw material, less than 1 wt % of the boron-containing catalyst (with respect to the amount of the raw material) is added, and then the temperature is gradually increased to the reaction temperature under atmospheric pressure or high pressure to perform the thermal decomposition/rearrangement reaction so as to obtain solid polycarbosilane (pcs) with a higher ceramic yield.
Institute Of Chemistry, Chinese Academy Of Science


 Novel compounds patent thumbnailnew patent Novel compounds
The invention is directed to certain novel compounds. Specifically, crystalline forms of n-[5-[4-(5-{[(2r,6s)-2,6-dimethyl-4-morpholinyl]methyl}-1,3-oxazol-2-yl)-1h-indazol-6-yl]-2-(methyloxy)-3-pyridinyl]methanesulfonamide and crystalline 6-(1h-indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1h-indazole, along with salts thereof..
Glaxo Group Limited


 Cyclopropene amino acids and methods patent thumbnailnew patent Cyclopropene amino acids and methods
The invention relates to a polypeptide comprising an amino acid having a cyclopropene group wherein said cyclopropene group is joined to the amino acid via a carbamate group. Suitably the cyclopropene group is a 1,3-disubstituted cyclopropene such as a 1,3-dimethylcyclopropene.
Medical Research Council


 Method for the synthesis of supported gold (au) nanoparticles for epoxidation reactions patent thumbnailnew patent Method for the synthesis of supported gold (au) nanoparticles for epoxidation reactions
Processes for preparing supported gold nanoparticle catalysts are provided. In an exemplary embodiment, the process includes adding a solution of a phosphorus compound to a solution of chloro (dimethyl sulfide) gold (i) to obtain a solution of chloro (phosphorus compound) gold (i) complex, adding the solution of chloro (phosphorus compound) gold (i) complex to a solution of silver nitrate to obtain a solution of nitro (phosphorus compound) gold (i) complex, applying the solution of nitro (phosphorus compound) gold (i) complex to a metal hydroxide support, drying the metal hydroxide support; and calcining the dried metal hydroxide support to form the supported gold nanoparticle catalyst.
Sabic Global Technologies B.v.


 Anti-fouling membranes patent thumbnailnew patent Anti-fouling membranes
A membrane assembly is provided. The membrane assembly comprises a membrane having a first surface and an opposing second surface, and a layer of anti-fouling polymer selected from the group consisting of an optionally functionalized hyperbranched polyglycerol, a hyperbranched polyimine, a zwitterionic copolymer obtainable by polymerizing 2-methacryloyloxyethyl lipoate with at least one of [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl) ammonium hydroxide or 2-methacryloyloxyethylphosphorylcholine, and combinations thereof arranged on the first surface of the membrane.
National University Of Singapore


 Agent for sedating response to external stimulation in skin and  sedating that response patent thumbnailnew patent Agent for sedating response to external stimulation in skin and sedating that response
An object of the present invention is to provide an agent for sedating the response of skin to external stimulation. The aforementioned object was achieved by finding a component that promotes cd39 gene expression in langerhans cells.
Shiseido Company, Ltd


 Electric double-layer capacitor patent thumbnailElectric double-layer capacitor
An electric double-layer capacitor contains an electrolytic solution, wherein the electrolytic solution comprises 1.2 to 1.8 mol/l of spirobipyrrolidinium tetrafluoroborate as electrolyte as well as solvent, where the solvent contains 50 to 60 percent by volume of propylene carbonate, 30 to 36 percent by volume of dimethyl carbonate, and 4 to 20 percent by volume of ethyl methyl carbonate. The electric double-layer capacitor can maintain its initial high capacitance and low internal resistance, while undergoing smaller characteristic changes after being exposed to low-temperature environments, high-voltage environments or high-temperature environments..
Taiyo Yuden Co., Ltd.


 In-situ heated deposition of parylene to enhance pore penetration into silicone patent thumbnailIn-situ heated deposition of parylene to enhance pore penetration into silicone
A composition of matter is described in which a porous material, such as polydimethylsiloxane (pdms), is coated with parylene n, c, d, or af-4 by vapor deposition polymerization while a temperature of the porous material's surface being coated is heated to between 60° c. And 120° c., or 80° c.
California Institute Of Technology


 Anti-fog compositions and processes for making same patent thumbnailAnti-fog compositions and processes for making same
Anti-fog compositions comprising a primary film having opposing major planar surfaces and a central coplanar region disposed between the opposing major planar surfaces and comprising cellulose acetate and a plasticizer. The cellulose acetate may have a degree of substitution less than 2.6.
Celanese International Corp.


Spiral-type separation membrane element

The objective of the present invention is to provide a spiral-type separation membrane element having superior oxidant resistance relative to the prior art, and a salt-blocking rate that tends not to decrease. The spiral-type separation membrane element is characterized in including: a supply-side flow-path material; a composite semipermeable membrane in which a skin layer is formed on the surface of a porous support, the skin layer containing a polyamide resin obtained by interfacial polymerization of a polyfunctional amine component and a polyfunctional acid halogen component; and a permeation-side flow-path material, wherein the polyfunctional amine component contains n,n′-dimethyl-meta-phenylenediamine and the permeation-side flow-path material has a porosity of 40 to 75%..
Nitto Denko Corporation

Stable veterinary anthelmintic formulations

Described herein are stable veterinary formulations and methods of treatment and use, comprising at least one macrocyclic lactone and levamisole as active anthelmintic agents, optionally also with at least one benzimidazole class anthelmintic, wherein the actives are solubilised together in a solvent system comprising dimethylsulfoxide (dmso). The veterinary formulations, methods and use thereof include the ability to deliver two or more anthelmintic actives in the one solution (or suspension) whilst also maintaining formulation stability when stored over a period of time.
Donaghys Limited

Anhydrous antiperspirant composition in aerosol form comprising an antiperspirant active agent and a water-insoluble film-forming block ethylenic polymer

Anhydrous antiperspirant composition in aerosol form comprising an antiperspirant active agent and a water-insoluble film-forming block ethylenic polymer the present invention relates to an anhydrous composition in aerosol form containing: i) an oily phase comprising, in a physiologically acceptable medium: —at least one volatile oil, and —one or more antiperspirant active agents chosen from aluminium and/or zirconium salts, and —one or more water-insoluble film-forming block ethylenic polymers comprising a first block with a glass transition temperature (tg) of greater than or equal to 85° c. And a second block with a tg of less than or equal to 20° c., and ii) one or more propellants; the said oily phase containing less than 15% by weight and even more preferably less than 12% by weight of non-volatile polydimethylsiloxane relative to the total weight of the oils.
L'oreal

Composition for preparing a polymeric foam

The present invention relates to composition for the preparation of a polymeric foam with improved thermal properties, to a polymeric foam obtainable therefrom, and to a method for preparing such a polymeric foam each for them comprising (i) an at least essentially amorphous polymer resin and (ii) a nucleating agent. The at least essentially amorphous polymer resin is preferably polystyrene.
Clariant International, Ltd.

Terephthalate derivatives and compositions thereof

The present invention provides dimethylterephthalate in which two of the aromatic ring carbons are derived from ethanol. The present invention also provides bis (2-hydroxyethyl) terephthalate, wherein two to six carbon atoms in a molecule can be derived from ethanol..

Method for synthesising dimethyl carbonate

A method for synthesising dimethyl carbonate from methanol and urea, in which a saline ureic medium is used that includes at least one inorganic salt selected from the group made up of zinc (zn) (ii) chloride, tin (sn) chlorides and iron (fe) (iii) chloride, characterised in that: methanol, in the presence of a catalytic composition, is placed in contact with the saline ureic medium that is at least partially liquid at a temperature referred to as synthesis temperature, which is higher than 140° c., such that reaction vapours are produced; the reaction vapours are condensed, and a condensate of the reaction vapours is collected, including dimethyl carbonate; the method is carried out at atmospheric pressure. A method for enriching and purifying dimethyl carbonate is also described..
Institut National De La Recherche Agronomique

Method for preparing polyoxymethylene dimethyl ether carbonyl compound and methyl methoxyacetate

A method for preparing a polyoxymethylene dimethyl ether carbonyl compound and/or methyl methoxyacetate as intermediates for producing ethylene glycol, which comprises passing a raw material: polyoxymethylene dimethyl ether or methylal together with carbon monoxide and hydrogen gas through a reactor carrying an acidic molecular sieve catalyst, and performing a reaction to prepare a corresponding product under an appropriate condition where no other solvent is added, in which the process of the reaction is a gas-liquid-solid three-phase reaction, the raw material of polyoxymethylene dimethyl ether or methylal has a high conversion rate, each product has a high selectivity, the catalyst has a long service life, additional solvents are not required to be used, and reaction conditions are relatively mild.. .
Dalian Institute Of Chemical Physics, Chinese Academy Of Sciences

Process of production of 2,5-dimethylphenol

The present invention relates to a new method to produce 2,5-dimethylphenol (2,5-dmp).. .
Dsm Ip Assets B.v.

Non-invasive monitoring cancer using integrated microfluidic profiling of circulating microvesicles

A microfluidic exosome profiling platform integrating exosome isolation and targeted proteomic analysis is disclosed. This platform is capable of quantitative exosomal biomarker profiling directly from 30 μl plasma samples within approximately 100 minutes with markedly enhanced sensitivity and specificity.

Reaction device for preparing light olefins from methanol and/or dimethyl ether

A reaction device for preparing light olefins from methanol and/or dimethyl ether, and more specifically relates to a reaction device for preparing light olefins from methanol and/or dimethyl ether, which mainly comprises a dense phase fluidized bed reactor (2), a cyclone separator (3), a stripper (5), a lift pipe (7), a dense phase fluidized bed regenerator (10), a cyclone separator (11), a stripper (13), and a lift pipe (15), wherein the dense phase fluidized bed reactor (2) is separated into n (n≧2) secondary reaction zones by a material flow controller (17), and the dense phase fluidized bed regenerator (10) is separated into m (m≧2) secondary regeneration zones by the material flow controller (17).. .
Dalian Institute Of Chemical Physics, Chinese Academy Of Sciences

Dimethyl fumarate and vaccination regimens

Provided herein is a method of treating or preventing a disease or disorder (e.g., ms) in a subject in need thereof, comprising (a) administering to the subject a first dose of a pharmaceutical composition comprising a fumarate agent (e.g., dmf) for a first dosing period; (b) administering a vaccine; and (c) administering to the subject a second dose of the pharmaceutical composition for a second dosing period.. .
Biogen Ma Inc.

Antifungal compositions for the treatment of skin and nails

The invention concerns a composition and method for treating an ungual infection, the composition comprising an iodophor and dimethylsulfoxide (dmso).. .
Veloce Biopharma, Llc

Pharmaceutical composition including 5--2,2-dimethyl-4-(3-fluorophenyl)-3(2h)-furanone and capsule formulation including the pharmaceutical composition

The present invention relates to a pharmaceutical composition including (i) the compound of formula 1 described in the specification or a pharmaceutically acceptable salt thereof, (ii) a pharmaceutically acceptable diluent, and (iii) a pharmaceutically acceptable lubricant. The compound of formula 1 or pharmaceutically acceptable salt thereof has a 50% volume particle diameter (d(0.5)) of 3 μm to 9 μm.
Crystalgenomics, Inc.

Lyophilized pharmaceutical compositions

The invention provides a method of preparing a lyophilized pharmaceutical composition containing a compound described herein or a pharmaceutically-acceptable salt thereof. The process comprises dissolving the compound in a solvent comprising dimethylsulfoxide and optionally one or more co-solvents to form a solution, and then removing the solvent and any co-solvents by a freeze-drying process.
Astex Pharmaceuticals, Inc.

Electrochromic thermoplastics, devices, and composites

An electrochromic thermoplastic composition includes about 10 wt % to about 60 wt % a poly(vinyl alcohol), a poly(acrylic acid), a poly(acrylic acid) salt, a polyaniline salt, a poly(diallyl dimethyl ammonium chloride), a poly(ethylene-co-acrylic acid), a co-polymer of any two or more thereof, or a mixture of any two or more thereof; about 40 wt % to about 90 wt % of a protic solvent; and at least one electroactive material; wherein the composition does not include lithium chloride, tetrabutylammonium bromide, lithium bis(trifluoromethanesulfonyl)imide, lithium triflate, and lithium hexafluorophosphate.. .
Gentex Corporation

Perfume composition

Provided is a fragrance composition containing a compound that has citrus and green odors as well as a floral-like odor in good balance, has excellent harmonicity with various other fragrances, emphasizes odors by being blended, and imparts a fresh floral feeling. A fragrance composition containing 4,7-dimethyloctan-3-ol.
Kao Corporation

Polylactic acid (pla) with low moisture vapor transmission rates by grafting through of hydrophobic polymers directly to pla backbone

Polylactic acid-backbone graft and bottlebrush copolymers with low moisture vapor transmission rates are synthesized by polymerizing a lactide-functionalized hydrophobic macromonomer using ring-opening polymerization (rop). In some embodiments of the present invention, the macromonomer is a lactide-functionalized hydrophobic polymer that may be synthesized by, for example, polymerizing a hydrophobic monomer (e.g., a fluorinated vinyl monomer such as 2,2,2-trifluroethyl methacrylate) capable of undergoing radical polymerization (e.g., styrenic, vinylic, acrylic, etc.) using a brominated lactide initiator via atom transfer radical polymerization (atrp).
International Business Machines Corporation

Etoposide and doxorubicin conjugates for drug delivery

The invention relates to improvements in the field of drug delivery. More particularly, the invention relates to polypeptides having a hydrolyzable covalent bond to a therapeutic agent that includes, etoposide, etoposide 4′-dimethylglycine or doxorubicin.
Angiochem Inc.

Nonaqueous electrolytic solution for electric double layer capacitor

Provided is a nonaqueous electrolytic solution that provides an electric double layer capacitor having excellent durability. The nonaqueous electrolytic solution is prepared by dissolving a quaternary ammonium salt as an electrolyte in a nonaqueous solvent, and the nonaqueous electrolytic solution comprises a diethylpyrrolidinium salt and/or a 1-ethyl-1,3-dimethylpyrrolidinium salt..
Otsuka Chemical Co., Ltd.

Fuel and process for powering a compression ignition engine

A diesel engine fuel composition including methanol, at least 5% by weight water, one or more additives selected from the group consisting of: ignition improvers, fuel extenders, combustion enhancers, oxygen absorbing oil, lubricity additives, product colouration additives, flame colour additives, anti corrosion additives, biocides, freeze point depressants, deposit reductants, denaturants, ph controlling agents, and mixtures thereof, and 0% to 20% by weight dimethyl ether. Also provided is a process of powering a compression ignition engine using such a diesel engine fuel..
Gane Energy & Resources Pty Ltd.

Optically active form of mepenzolate, and ameliorating agent for chronic obstructive pulmonary disease which contains same as active ingredient

An optically active form of mepenzolate bromide is provided. An agent for ameliorating chronic obstructive pulmonary disease that contains the optically active form as an active ingredient and is based on a bronchodilator effect and an anti-inflammatory effect is also provided.
Ltt Bio-pharma Co., Ltd.

Reductive preparation of tertiary dimethylamines from nitriles

This disclosure describes a low temperature process for the preparation of dimethyl amines from nitriles via reductive amination. In some embodiments, the process proceeds under mild conditions with aqeuous dimethylamine and show an unexpected rate acceleration by the inclusion of an acid addition salt of the dimethylamine..
Eastman Chemical Company

Methods of producing para-xylene and terephthalic acid

The present disclosure provides methods to produce para-xylene, toluene, and other compounds from renewable sources (e.g., cellulose, hemicellulose, starch, sugar) and ethylene in the presence of a catalyst. For example, cellulose and/or hemicellulose may be converted into 2,5-dimethylfuran (dmf), which may be converted into para-xylene by cycloaddition of ethylene to dmf.
Micromidas, Inc.

Combinations of trametinib, panitumumab and dabrafenib for the treatment of cancer

A novel combination comprising a b-raf inhibitor, particularly n-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, and/or the mek inhibitor n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or a pharmaceutically acceptable salt or solvate thereof, and panitumumab (vectibix); pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of mek and/or b-raf and/or egfr is beneficial, eg. Cancer..
Novartis Ag

Compounds and methods for treating aberrant adrenocortical cell disorders

Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (acc), cushing's syndrome and/or pituitary acth excess (cushing's disease). Such methods involve administration of an effective amount n-(2,6-bis(1-methylethyl)phenyl)-n′-((1-(4-(dimethyl amino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient..
The Regents Of The University Of Michigan

Method of modifying substrate surface

A method of modifying substrate surface includes: performing an o2 plasma treatment on a substrate including polydimethylsiloxane (pdms); coating hydrophilic uv curing coating uniformly on the substrate; disposing the substrate into an oxygen-free environment; and exposing to an uv light to cure the hydrophilic uv curing coating. The method of modifying substrate surface may greatly enhance the hydrophilicity and the stability of the pdms substrate..
National Tsing Hua University

Synthesis gas conversion process

The disclosed invention relates to a method for restarting a synthesis gas conversion process which has stopped. The synthesis gas conversion process may be conducted in a conventional reactor or a microchannel reactor.
Velocys, Inc.

Fire and smoldering resistant article

A fire and smoldering resistant article includes: a fabric; a coating composition to provide resistance to fire and smoldering of the article, the coating composition disposed on the fabric and including: a cross-linked silicone polymer; and a metal hydroxide disposed among the silicone polymer; and a mesh interposed between the fabric and the coating composition, wherein the cross-linked silicone polymer includes: a reaction product of polydimethylsiloxane (pdms); a reaction product of a hydroxy modified pdms; a reaction product of a vinyl modified pdms; or a combination including at least one of the foregoing silicone polymers.. .
National Institute Of Standards And Technology

Process for the preparation of 5-fluorotryptophol

The present invention relates to a process for the preparation of 5-fluorotryptophol as well as a process for the preparation of (1r,4r)-6′-fluoro-n,n-dimethyl-4-phenyl-4′,9′-dihydro-3′h-spiro[cyclohexane-1,1′-pyrano-[3,4b]-indol]-4-amine using the 5-fluorotryptophol obtained by said first process. The process according to the invention provides 5-fluorotryptophol in improved yield and purity without the need for chromatographic purification of the product..
Gruenenthal Gmbh

Methods of producing para-xylene and terephthalic acid

The present disclosure provides methods to produce para-xylene, toluene, and other compounds from renewable sources (e.g., cellulose, hemicellulose) and ethylene in the presence of an acid, such as a lewis acid. For example, cellulose and/or hemicellulose may be converted into 2,5-dimethylfuran (dmf) and 2-methylfuran, which may be converted into para-xylene and toluene, respectively.
Micromidas, Inc.

Method of fabricating oil product of gasoline

An oil product of gasoline is fabricated. The product contains hydrocarbon compound ranged as a gasoline composition.
Institute Of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.o.c.

Refractory castables with hydrophobic aggregates

Hydrophobic aggregates for use in refractory castables and gunning mixtures and methods of their preparation. The aggregates here are formed by crushing insulating fire brick and coating the resulting particles with a hydrophobic component.
Bnz Materials, Inc.

Pharmaceutical dosage forms comprising 6'-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine

A pharmaceutical dosage form for administration twice daily, once daily or less frequently, which contains 6′-fluoro-(n-methyl- or n,n-dimethyl)-4-phenyl-4′,9′-dihydro-3′h-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine or a physiologically acceptable salt thereof.. .
Gruenenthal Gmbh

Pharmaceutical combination

A combination comprising as components (a) the compound 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol, and (b) one or more non-steroidal anti-inflammatory drugs (nsaids); a pharmaceutical salt comprising said components; a compound derived from said components; a pharmaceutical formulation and a dosage form comprising said combination, salt, or compound; as well as a method of treating pain, e.g. Chronic or acute pain, in a mammal characterized in that components (a) and (b) are administered simultaneously or sequentially to a mammal, wherein component (a) may be administered before or after component (b) and wherein components (a) or (b) are administered to the mammal either via the same or a different pathway of administration..
Gruenenthal Gmbh



Dimethyl topics:
  • Physiologic
  • Hydrochloric Acid
  • Fresnel Zone
  • Aberration
  • Ophthalmic
  • Liquid Crystal
  • Imaging System
  • Pharmaceutically Acceptable Salt
  • Pharmaceutically Acceptable Salts
  • Chloric Acid
  • Tartaric Acid
  • Fumaric Acid
  • Antagonist
  • Bradykinin
  • Enantiomer


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Dimethyl for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Dimethyl with additional patents listed. Browse our RSS directory or Search for other possible listings.


    2.2487

    file didn't exist2339

    478893 - 0 - 52